跳至主要内容
临床试验/NCT01556178
NCT01556178已完成不适用

Collection of Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research

Ann & Robert H Lurie Children's Hospital of Chicago1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2011年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5
试验地点
1
主要终点
levels of miRNAs in the blood and CSF

研究概览

简要总结

In normal patients, blood and cerebrospinal fluid (CSF) contain circulating cells and other molecules such as proteins and nucleic acids. In patients with central nervous system (CNS) and other conditions, the levels of these molecules may be altered. In several other studies at our institution, the investigators are investigating such molecules in tumor specimens as well as the blood and cerebrospinal fluid of pediatric patients with CNS tumors. However, these levels are difficult to interpret without comparing them to levels in patients without CNS tumors. The investigators propose a study to collect small amounts of blood and cerebrospinal fluid from pediatric patients without CNS tumors who are undergoing a diagnostic or therapeutic neurosurgical procedure aimed at addressing altered CSF dynamics.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children without central nervous system tumors who are undergoing a neurosurgical procedure to address hydrocephalus during which CSF will be obtained
  • Between the ages of 1 year and 21 years
  • Patients must be having blood draws, lumbar punctures or CSF sampling from Ommaya reservoirs or VPS as part of routine clinical care.

排除标准

  • Patients who do not require routine blood draws and/or CSF collection as part of their routine clinical care
  • Patients who are considered too ill to participate as determined by their treating physician
  • Patients with documented bacterial of viral infections of the CSF, brain parenchyma and/or neurosurgical devices and/or
  • Patients with suspected de-myelinating conditions
  • Patients who are pregnant or lactating.

结局指标

主要结局

levels of miRNAs in the blood and CSF

时间窗: 2 yrs

次要结局

  • Survivin and biologic markers levels in the CSF and blood(2 yrs)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rishi Lulla

Principal Investigator

Ann & Robert H Lurie Children's Hospital of Chicago

研究点 (1)

Loading locations...

相似试验

终止
不适用
Cerebrospinal Fluid Collection and Repository StorageNervous System Diseases
NCT01862107National Institute of Neurological Disorders and Stroke (NINDS)51
招募中
不适用
Frequency of genetic mutation in Korean Frontotemporal dementia patientsDiseases of the nervous system
KCT0000685Pusan National University Hospital100
已完成
不适用
Cerebrospinal Fluid RepositoryAmyotrophic Lateral SclerosisCerebrospinal FluidNeurodegenerative DiseaseMotor Neuron Disease
NCT00714636Drexel University College of Medicine11
进行中(未招募)
不适用
Cerebrospinal fluid (CSF) and plasma pharmocokinetics of liposomal cytarabine (DepoCyte®) after intrathecal administration in children with malignant brain tumors and leptomeningeal disseminatioTo measure concentrations of liposomal cytarabine in CSF and plasma over time after intrathecal administration of liposomal cytarabine in children of different age groups with a malignant brain tumor and leptomenigeal dissemination. Measurements of concentrations of cytarabine after intrathecal administration of liposomal cytarabine will help to ensure proper dosage of liposomal cytarabine in small children, avoiding neurotoxic events and subtherapeutic drug levels.
EUCTR2006-004982-32-ATMedical University of Vienna, Department of Pedatrics
已完成
不适用
Plasma and cerebrospinal fluid concentrations treated with daily dose and high dose weekly erlotinib in non-small cell lung cancer patients with central nervous system metastasescentral nervous system metastases of non-small cell lung cancer with active EGFR mutations treated with daily dosing erlotinib
JPRN-UMIN000004703Osaka City University10
Blood and Cerebrospinal Fluid for Pediatric Brain... | 临床试验